We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.55%
2 Healthcare 10.82%
3 Consumer Discretionary 9.19%
4 Financials 8.34%
5 Communication Services 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMIC
3926
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$18K ﹤0.01%
154
-82
-35% -$9.62K
NXTP
3927
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$18K ﹤0.01%
+2,609
New +$18.1K
CYT
3928
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$18K ﹤0.01%
6,000
+1,442
+32% +$3.68K
GENY
3929
DELISTED
Principal Exchange-Traded Funds Principal Millennial Global Growth ETF
GENY
$18K ﹤0.01%
462
-571
-55% -$24.6K
BLU
3930
DELISTED
BELLUS Health Inc.
BLU
$18K ﹤0.01%
1,950
+309
+19% +$2.53K
LDHAU
3931
DELISTED
LDH Growth Corp I Units
LDHAU
$18K ﹤0.01%
1,869
+1,821
+3,794% +$17.9K
RKLY
3932
DELISTED
Rockley Photonics Holdings Limited
RKLY
$18K ﹤0.01%
8,468
+3,389
+67% +$10.4K
BTRS
3933
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$18K ﹤0.01%
3,523
+1,448
+70% +$8.33K
SHAC
3934
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
$18K ﹤0.01%
1,800
-6
-0.3% -$59
TMX
3935
DELISTED
Terminix Global Holdings, Inc.
TMX
$18K ﹤0.01%
436
+45
+12% +$1.95K
CTT
3936
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$18K ﹤0.01%
1,797
+1,021
+132% +$9.35K
APEI icon
3937
American Public Education
APEI
$826M
$17K ﹤0.01%
1,045
-307
-23% -$5.23K
ARKO icon
3938
ARKO Corp
ARKO
$500M
$17K ﹤0.01%
2,143
-25,425
-92% -$221K
ASMB icon
3939
Assembly Biosciences
ASMB
$536M
$17K ﹤0.01%
680
-413
-38% -$9.51K
ASPS icon
3940
Altisource Portfolio Solutions
ASPS
$64.5M
$17K ﹤0.01%
199
-102
-34% -$8.89K
BGRN icon
3941
iShares USD Green Bond ETF
BGRN
$503M
$17K ﹤0.01%
+362
New +$17.5K
BH.A icon
3942
Biglari Holdings Class A
BH.A
$1.23B
$17K ﹤0.01%
29
+21
+263% +$13.9K
SRTA
3943
Strata Critical Medical Inc
SRTA
$533M
$17K ﹤0.01%
3,734
+2,259
+153% +$16.3K
BMRC icon
3944
Bank of Marin Bancorp
BMRC
$462M
$17K ﹤0.01%
549
+184
+50% +$5.95K
BSRR icon
3945
Sierra Bancorp
BSRR
$532M
$17K ﹤0.01%
794
-110
-12% -$2.46K
BY icon
3946
Byline Bancorp
BY
$1.78B
$17K ﹤0.01%
733
+522
+247% +$12.6K
CIX icon
3947
Comp X International
CIX
$386M
$17K ﹤0.01%
714
-593
-45% -$13.3K
CRBU icon
3948
Caribou Biosciences
CRBU
$160M
$17K ﹤0.01%
3,068
-1,613
-34% -$12.3K
CURI icon
3949
CuriosityStream
CURI
$237M
$17K ﹤0.01%
9,745
+6,347
+187% +$12.8K
EVER icon
3950
EverQuote
EVER
$867M
$17K ﹤0.01%
1,940
+1,752
+932% +$20K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.